[1]刘成龙,耿立梅,马蕴蕾,等.中医药治疗慢性阻塞性肺疾病的研究进展[J].西部中医药,2022,35(02):153-156.[doi:10.12174/j.issn.2096-9600.2022.02.39]
　LIU Chenglong,GENG Limei,MA Yunlei,et al.Research Progress of TCM Therapy for COPD[J].Western Journal of Traditional Chinese Medicine,2022,35(02):153-156.[doi:10.12174/j.issn.2096-9600.2022.02.39]
点击复制

中医药治疗慢性阻塞性肺疾病的研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年02期
页码:
153-156
栏目:
研究进展
出版日期:
2022-02-15

文章信息/Info

Title:
Research Progress of TCM Therapy for COPD
作者:
刘成龙1, 耿立梅2, 马蕴蕾2, 张宇宇1,2, 张依梦1,2, 薛滢1,2, 李方1,2
1.河北中医学院研究生院，河北 石家庄 050000
2.河北中医学院附属医院
Author(s):
LIU Chenglong1, GENG Limei2, MA Yunlei2, ZHANG Yuyu1,2, ZHANG Yimeng1,2, XUE Ying1,2, LI Fang1,2
1.Graduate School, Hebei University of Chinese Medicine, Shijiazhuang 050000, China
2.Affiliated Hospital of Hebei University of Chinese Medicine
关键词:
慢性阻塞性肺疾病; 病因病机; 辨证方法; 中医治法
Keywords:
COPD; the cause and pathogenesis; the methods of syndrome differentiation; TCM therapeutic methods
分类号:
R714.253
DOI:
10.12174/j.issn.2096-9600.2022.02.39
文献标志码:
A
摘要:
从病因病机、辨证论治、治法三方面入手，对近几年中医治疗慢性阻塞性肺疾病文献进行梳理，探讨中医对该病的认识及目前采用的中医疗法，展示中医药治疗该病的广阔前景。
Abstract:
The article discusses TCM understanding to COPD and the specific methods of TCM therapy in treating COPD from the cause and pathogenesis, syndrome differentiation and treatment and therapeutic methods by combing the literature on TCM in treating COPD in the recent years, which shows the broad prospects of TCM in treating COPD.

相似文献/References:

[1]李翼哲,李庆兵,吉海春,等.“寒”在大骨节病病因病机中的作用[J].西部中医药,2011,24(11):16.
[2]潘文,王贵霞,王晓萍.多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用[J].西部中医药,2012,25(12):121.
　PAN Wen,WANG Gui-xia,WANG Xiao-ping.Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(02):121.
[3]汝亚琴,金智生.中医药治疗年龄相关性黄斑变性研究进展[J].西部中医药,2013,26(09):141.
　RU Yaqin,JIN Zhisheng.Research Progress on TCM Treating Age-related Macular Degeneration[J].Western Journal of Traditional Chinese Medicine,2013,26(02):141.
[4]黄清杰,李茂星,刘 雄△.中医治疗药物性肝损伤研究进展[J].西部中医药,2012,25(07):124.
　HUANG Qing-jie,LI Mao-xing,LIU Xiong.Progress of Study on Treatment of Drug-induced Liver Injury with TCM[J].Western Journal of Traditional Chinese Medicine,2012,25(02):124.
[5]王萍.慢性阻塞性肺病患者实施临床护理路径的疗效分析[J].西部中医药,2014,27(11):140.
[6]王 燕,孙凤英,倪 军.慢性阻塞性肺疾病患者非药物治疗依从性与生活质量相关性的研究[J].西部中医药,2015,28(03):89.
[7]郭晓燕,尹广超,陆城华,等.川芎平喘合剂对COPD患者血管内皮功能的调节作用[J].西部中医药,2015,28(05):1.
[8]王振伟,杨佩兰,沈丽,等.百部养肺煎膏治疗COPD稳定期患者的临床研究[J].西部中医药,2015,28(05):56.
[9]高世东.从肝脾肾论治高脂血症[J].西部中医药,2013,26(06):18.
　GAO Shidong.On Hyperlipoidemia Treated from Liver, Spleen and Kidney[J].Western Journal of Traditional Chinese Medicine,2013,26(02):18.
[10]赵宇冰,林丽明.老年慢性阻塞性肺疾病患者缓解期的社区康复治疗[J].西部中医药,2012,25(08):59.
　ZHAO Yu-bing,LIN Li-ming.Community Rehabilitation Therapy for Senile Patients with COPD at Remission Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(02):59.

备注/Memo

备注/Memo:
刘成龙（1989—），男，硕士学位，住院医师。研究方向：呼吸系统疾病的中西医结合诊治。河北省财政厅项目（361-0402-YSN-ULZ6）。
更新日期/Last Update: 2022-06-22